Gafter U, Barak H, Hirsh J, Edelstein S, Levi J
Department of Nephrology, Hasharon Hospital, Petah-Tiqva, Israel.
Miner Electrolyte Metab. 1990;16(6):391-4.
The effect of verapamil in vitro, and the in vivo effect of both oral and parenteral verapamil administration on intestinal absorption was tested using everted gut sacs of duodenum, jejunum, distal ileum and proximal colon in rats. In the in vivo study, the effect of verapamil on blood levels of calcium, phosphorus and 1.25(OH)2D3, was investigated and a complete calcium balance was performed. In vitro, verapamil (1.5 mM) inhibited calcium absorption by the duodenum and colon only. Oral verapamil led to a reduction in the blood level of 1.25(OH)2D3. However, both oral and parenteral verapamil had no effect on the intestinal absorption, urinary secretion and consequently on the calcium balance.
使用大鼠十二指肠、空肠、回肠末端和近端结肠的外翻肠囊,测试了维拉帕米的体外作用以及口服和胃肠外给予维拉帕米对肠道吸收的体内作用。在体内研究中,研究了维拉帕米对钙、磷和1,25(OH)₂D₃血药浓度的影响,并进行了完整的钙平衡研究。在体外,维拉帕米(1.5 mM)仅抑制十二指肠和结肠的钙吸收。口服维拉帕米导致1,25(OH)₂D₃血药浓度降低。然而,口服和胃肠外给予维拉帕米对肠道吸收、尿分泌以及因此对钙平衡均无影响。